84 notices found. Showing 51–84.
| Document № | Drug | Registration № | Level | Type | Source |
|---|---|---|---|---|---|
|
6058/QLD-CL
2021-05-28
|
Atisalbu oral solution
Official Letter No. 6058/QLD-CL notifying the recall of a drug with a level 3 violation (Atisalbu oral solution (Salbutamol 2mg/5ml))
|
— | Level 3 | Quality violation | |
|
615/QLD-CL
2021-02-01
|
Tobraquin
Official Letter No. 615/QLD-CL on the notification of the recall of Tobraquin
|
— | — | Other | |
|
35/QLD-CL
2021-01-07
|
B - COMENE injection
Official Letter No. 35/QLD-CL on the notification of the recall of a drug with a level 2 violation (B - COMENE injection, Reg. No.: VN-18188-14, Batch no.: 190811; Mfg. date: 11/08/2019; Exp.: 10/08/2022)
|
VN-18188-14 | Level 2 | Quality violation | |
|
18286/QLD-CL
2020-12-11
|
Bronzoni soft capsules
Official Letter No. 18286/QLD-CL on the notification of the recall of a drug with a level 3 violation (Bronzoni soft capsules)
|
— | Level 3 | Quality violation | |
|
17570/QLD-CL
2020-11-27
|
Sedtyl
Official Letter No. 17570/QLD-CL on the notification of the recall of Sedtyl, batch no. 02L19
|
— | — | Other | |
|
17463/QLD-CL
2020-11-25
|
Sedtyl
Official Letter No. 17463/QLD-CL on the notification of the recall of Sedtyl, batch 03M19
|
— | — | Other | |
|
17330/QLD-CL
2020-11-23
|
Atibutrex
Official Letter No. 17330/QLD-CL on the notification of the recall of Atibutrex due to a level 2 violation
|
— | Level 2 | Quality violation | |
|
16984/QLD-CL
2020-11-17
|
Dacodex soft capsules
Official Letter No. 16984/QLD-CL on the notification of the recall of a drug with a level 3 violation (Dacodex soft capsules)
|
— | Level 3 | Quality violation | |
|
16746/QLD-CL
2020-11-10
|
Protamine Choay 1000 U.A.H/ml solution for injection
Official Letter No. 16746/QLD-CL on the quality of Protamine Choay 1000 U.A.H/ml solution for injection
|
— | — | Other | |
|
15052/QLD-CL
2020-09-17
|
Trimoxtal
Official Letter No. 15052/QLD-CL on the notification of the recall of Trimoxtal, Reg. No.: VD-20158-13
|
VD-20158-13 | — | Other | |
|
12222/QLD-CL
2020-08-05
|
Detracyl 250 sugar-coated tablets
Official Letter No. 12222/QLD-CL on the suspension from circulation of a drug failing to meet quality standards: Detracyl 250 sugar-coated tablets (Mephenesin 250mg), Reg. No.: VD-20186-13, Batch no.: 61100718
|
VD-20186-13 | — | Quality violation | |
|
11924/QLD-CL
2020-07-31
|
Genpharmason
Official Letter No. 11924/QLD-CL on the notification of the recall of a drug with a level 2 violation (Genpharmason)
|
— | Level 2 | Quality violation | |
|
11444/QLD-CL
2020-07-24
|
Navacarzol 5mg tablets
Official Letter No. 11444/QLD-CL on the notification of the recall of a drug with a quality violation (Navacarzol 5mg tablets)
|
— | — | Quality violation | |
|
6526/QLD-CL
2020-05-26
|
Captopril 25mg
Official Letter No. 6526/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Captopril 25mg)
|
— | — | Quality violation | |
|
5555/QLD-CL
2020-05-06
|
Dekasiam
Official Letter No. 5555/QLD-CL on the suspension from circulation of Dekasiam, which fails to meet quality standards
|
— | — | Quality violation | |
|
3425/QLD-CL
2020-04-09
|
Incepban 400 Chewable Tablet chewable tablets
Official Letter No. 3425/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Incepban 400 Chewable Tablet chewable tablets (Albendazole 400mg))
|
— | — | Quality violation | |
|
2899/QLD-CL
2020-03-29
|
Alsoben tablets
Official Letter No. 2899/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Alsoben tablets)
|
— | — | Quality violation | |
|
2865/QLD-CL
2020-03-27
|
Chloramphenicol 250 mg
Official Letter No. 2865/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Chloramphenicol 250 mg)
|
— | — | Quality violation | |
|
2808/QLD-CL
2020-03-26
|
B-Comene injection
Official Letter No. 2808/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (B-Comene injection)
|
— | — | Quality violation | |
|
2240/QLD-CL
2020-03-11
|
Tre Viet granules
Official Letter No. 2240/QLD-CL on the suspension from circulation of Tre Viet granules, which fail to meet quality standards
|
— | — | Quality violation | |
|
838/QLD-CL
2020-01-31
|
Buclapoxime film-coated tablets
Official Letter No. 838/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Buclapoxime film-coated tablets (Cefpodoxime Proxetil Tablets USP 200 mg))
|
— | — | Quality violation | |
|
235/QLD-CL
2020-01-14
|
Young II Captopril Tablet tablets
Official Letter No. 235/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Young II Captopril Tablet tablets (Captopril 25mg))
|
— | — | Quality violation | |
|
20787/QLD-CL
2019-12-12
|
LIV-Z Tablets tablets
Official Letter No. 20787/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (LIV-Z Tablets tablets)
|
— | — | Quality violation | |
|
19942/QLD-CL
2019-11-28
|
Young II Captopril
Official Letter No. 19942/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Young II Captopril)
|
— | — | Quality violation | |
|
19781/QLD-CL
2019-11-26
|
Ceteco Melocen 7
Official Letter No. 19781/QLD-CL on the suspension from circulation of Ceteco Melocen 7.5, which fails to meet quality standards
|
— | — | Quality violation | |
|
19664/QLD-CL
2019-11-22
|
Aciclovir
Official Letter No. 19664/QLD-CL on the recall of Aciclovir, which fails to meet quality standards
|
— | — | Quality violation | |
|
16814/QLD-CL
2019-10-02
|
Ranitidine
Official Letter 16814/QLD-CL on the recall of Ranitidine-containing drugs with NDMA impurity levels exceeding the permitted limit
|
— | — | Other | |
|
16457/QLD-CL
2019-09-24
|
Clavophynamox 1000
Official Letter 16457/QLD-CL on the recall of Clavophynamox 1000, which fails to meet quality standards
|
— | — | Quality violation | |
|
6346/QLD-CL
2019-04-26
|
Cetirizine tablets 10mg
Official Letter 6346/QLD-CL on the suspension from circulation of a drug failing to meet quality standards (Cetirizine tablets 10mg)
|
— | — | Quality violation | |
|
3828/QLD-CL
2019-03-25
|
Diuresin SR
Official Letter No. 3828/QLD-CL suspending from circulation a drug failing to meet quality standards (Diuresin SR (Indapamide 1.5mg))
|
— | — | Quality violation | |
|
883/QLD-CL
2019-01-25
|
Peridom-M film-coated tablets
Official Letter No. 883/QLD-CL suspending from circulation a drug failing to meet quality standards (Peridom-M film-coated tablets)
|
— | — | Quality violation | |
|
884/QLD-CL
2019-01-25
|
Chymomedi
Official Letter No. 884/QLD-CL suspending from circulation a drug failing to meet quality standards (Chymomedi (Chymotrypsin 21 microkatals))
|
— | — | Quality violation | |
|
—
2018-09-14
|
Koreamin injection
Suspension from circulation of a drug failing to meet quality standards (Koreamin injection)
|
— | — | Quality violation | |
|
—
2018-07-06
|
Unicet film-coated tablets
Suspension from circulation of a drug failing to meet quality standards (Unicet film-coated tablets (Cetirizin hydroclorid 10mg))
|
— | — | Quality violation |
Reference data. Decision number, drug name, registration number and violation level are parsed automatically from each notice title, so some notices may leave these fields blank. Verify against the signed recall decision PDF before relying on it for legal purposes.